Fagron NV (LON:0HNZ)
London flag London · Delayed Price · Currency is GBP · Price in EUR
22.35
+0.05 (0.22%)
At close: Jul 25, 2025

Fagron NV Company Description

Fagron NV, a pharmaceutical compounding company, delivers personalized pharmaceutical care to hospitals, pharmacies, clinics, patients, and worldwide.

It operates through three segments: Essentials, Brands, and Compounding Services. The company products include DiluCap, a line of excipients to compound every capsule formulation; Imuno TF Complex helps in regulation of immune responses; Pigmerise, a natural phytocomplex for hypopigmentation disorders, such as vitiligo; Pentravan uses for avoiding first-pass metabolism and preventing gastrointestinal erosion; Nourisil MD, a first line therapy for prevention and treatment of scars ang keloids; Neogen, a line of hair care products; TrichoConcept used to treat alopecia; Fagron Advanced Derma for basic skincare, compound pharmaceutical treatment, and individualized dermatological care; SyrSpend SF that provides pharmaceutical stability, dosage consistency, and patient comfort; and Cleoderm, a topical cream used for the compounding of personalized dermatological treatments.

It also offers education and professional development of prescribers and pharmacists through the Fagron Academy.

The company was formerly known as Arseus NV and changed its name to Fagron NV in January 2015. Fagron NV was founded in 1990 and is based in Nazareth, Belgium.

Fagron NV
CountryBelgium
Founded1990
IndustryMedical, Dental, and Hospital Equipment and Supplies
Employees3,828
CEORafael Padilla

Contact Details

Address:
Venecoweg 20A
Nazareth, 9810
Belgium
Phone32 800 128 80
Websitefagron.com

Stock Details

Ticker Symbol0HNZ
ExchangeLondon Stock Exchange
Fiscal YearJanuary - December
Reporting CurrencyEUR
ISIN NumberBE0003874915
SIC Code5047

Key Executives

NamePosition
Rafael PadillaChief Executive Officer and Executive Director
Karin de JongChief Financial Officer and Executive Director
Vera BakkerChief Operating Officer
Johan VerlindenHead of Legal, Mergers and Acquisitions